STARTUP PROFILE

Surf Therapeutics

COUNTRY
USA
FOUNDED
2023
CATEGORY
Neuromodulation
Developing a non-invasive ultrasound neuromodulation platform designed to engage the body’s anti-inflammatory neural pathways for treatment of chronic inflammatory disorders.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Ultrasound
FORM FACTOR
Other
INTERFACE DEPTH
Non-invasive
INDICATION
Other
TARGET USER
Patients
REGULATORY STAGE
Investigational
Surf Therapeutics is developing ultrasound-based neuromodulation aimed at anti-inflammatory neural pathways, making it more adjacent to bioelectronic medicine than central neurotechnology. Its ultrasound approach is distinctive, though still early.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Surf Therapeutics
No items found.